🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Judith M. Boer

Wroclaw Medical University

ORCID: 0000-0003-4848-7789

Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 3 papers. Top paper: “Tyrosine kinase inhibitor response of ABL-class acute lymphoblastic leukemia: the role of kinase type and SH3 domain”.

Tyrosine kinase inhibitor response of ABL-class acute lymphoblastic leukemia: the role of kinase type and SH3 domain

Blood(2024)10.1182/blood.2023023120

N/A

0.470DataRank · unranked

22 citations

Sarah K. Tasian, Caitlin E. J. Reichert, Aurélie Boeree, Hester A. de Groot‐Kruseman, Gabriele Escherich +3 more

Outcomes of paediatric patients with B-cell acute lymphocytic leukaemia with ABL-class fusion in the pre-tyrosine-kinase inhibitor era: a multicentre, retrospective, cohort study

The Lancet Haematology(2020)10.1016/s2352-3026(20)30353-7

N/A

0DataRank · unranked

66 citations

Gunnar Cario, Anthony V. Moorman, Judith M. Boer, Hester A. de Groot‐Kruseman, Marta Fiocco +19 more

From the bench of molecular understanding to the bedside of optimal therapy for BCR::ABL1 and ABL-class acute lymphoblastic leukemia in children and adolescents

EJC Paediatric Oncology(2025)10.1016/j.ejcped.2025.100304

N/A

0DataRank · unranked

3 citations

Judith M. Boer, Monique L. den Boer, Sarah K. Tasian